State of Michigan Retirement System Sells 600 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

State of Michigan Retirement System decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 1.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 33,888 shares of the company’s stock after selling 600 shares during the quarter. State of Michigan Retirement System’s holdings in Henry Schein were worth $2,345,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. LGT Group Foundation boosted its holdings in shares of Henry Schein by 9.0% in the 4th quarter. LGT Group Foundation now owns 289,568 shares of the company’s stock worth $20,038,000 after acquiring an additional 23,965 shares in the last quarter. Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Metis Global Partners LLC increased its stake in shares of Henry Schein by 4.7% in the fourth quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock valued at $291,000 after buying an additional 187 shares in the last quarter. SVB Wealth LLC bought a new position in shares of Henry Schein in the fourth quarter valued at about $345,000. Finally, Versor Investments LP acquired a new position in Henry Schein during the 4th quarter worth about $377,000. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HSIC. Jefferies Financial Group boosted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research reissued an “outperform” rating and issued a $90.00 price target on shares of Henry Schein in a report on Wednesday, February 26th. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Finally, UBS Group decreased their price target on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Price Performance

Shares of HSIC opened at $74.59 on Friday. The stock’s 50-day moving average price is $74.57 and its two-hundred day moving average price is $72.57. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.49. The stock has a market cap of $9.26 billion, a P/E ratio of 30.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the previous year, the business posted $0.66 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.